{"id":43535,"date":"2020-05-13T11:00:26","date_gmt":"2020-05-13T02:00:26","guid":{"rendered":"http:\/\/www.veeva.com\/jp\/?p=43535"},"modified":"2020-05-12T19:00:03","modified_gmt":"2020-05-12T10:00:03","slug":"veeva-introduces-new-capabilities-for-remote-drug-sampling-in-veeva-crm-engage-meeting","status":"publish","type":"post","link":"https:\/\/pantheon.veeva.com\/jp\/news\/veeva-introduces-new-capabilities-for-remote-drug-sampling-in-veeva-crm-engage-meeting\/","title":{"rendered":"Veeva\u3001Veeva CRM Engage Meeting\u306b\u30ea\u30e2\u30fc\u30c8\u30b5\u30f3\u30d7\u30ea\u30f3\u30b0\u6a5f\u80fd\u3092\u65b0\u305f\u306b\u8ffd\u52a0"},"content":{"rendered":"

\uff5e \u73fe\u5834\u62c5\u5f53\u8005\u306f\u30ea\u30e2\u30fc\u30c8\u30df\u30fc\u30c6\u30a3\u30f3\u30b0\u4e2d\u306b\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u3092\u9075\u5b88\u3057\u305f\u3046\u3048\u3067<\/p>\n

\u30b5\u30f3\u30d7\u30eb\u3092\u30aa\u30fc\u30c0\u30fc\u3057\u305f\u308a\u533b\u7642\u5f93\u4e8b\u8005\u306e\u30ea\u30af\u30a8\u30b9\u30c8\u306b\u5fdc\u3048\u305f\u308a\u3059\u308b\u3053\u3068\u304c\u53ef\u80fd\u306b<\/p>\n

\u4e16\u754c\u4e2d\u3067\u5bfe\u9762\u304c\u5236\u9650\u3055\u308c\u308b\u4e2d\u3001Veeva\u306f\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u306b\u3088\u308b\u533b\u7642\u5f93\u4e8b\u8005\u652f\u63f4\u3092<\/p>\n

\u6025\u901f\u306a\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3067\u30b5\u30dd\u30fc\u30c8 \uff5e<\/p>\n

 <\/p>\n

2020\u5e745\u670813\u65e5<\/p>\n

Veeva Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n

 <\/p>\n

Veeva Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b Veeva) \u306f\u3001Veeva CRM Engage Meeting<\/a><\/strong>\u306b\u30ea\u30e2\u30fc\u30c8\u30b5\u30f3\u30d7\u30ea\u30f3\u30b0\u6a5f\u80fd\u3092\u65b0\u305f\u306b\u8ffd\u52a0\u3059\u308b\u3053\u3068\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u30ea\u30e2\u30fc\u30c8\u30b5\u30f3\u30d7\u30ea\u30f3\u30b0\u306f\u3001\u73fe\u5834\u62c5\u5f53\u8005\u304c\u30ea\u30e2\u30fc\u30c8\u30df\u30fc\u30c6\u30a3\u30f3\u30b0\u4e2d\u306b\u533b\u7642\u5f93\u4e8b\u8005\u304b\u3089\u30d3\u30b8\u30cd\u30b9\u30ea\u30d7\u30e9\u30a4\u30ab\u30fc\u30c9\uff08BRC\uff09\u3068\u3082\u547c\u3070\u308c\u308b\u30b5\u30f3\u30d7\u30eb\u30ea\u30af\u30a8\u30b9\u30c8\u3092\u53d7\u3051\u4ed8\u3051\u3001\u51e6\u7406\u3067\u304d\u308b\u3088\u3046\u306b\u3059\u308b\u6a5f\u80fd\u3067\u3059\u3002\u3053\u308c\u306b\u3088\u308a\u3001\u30ea\u30e2\u30fc\u30c8\u30df\u30fc\u30c6\u30a3\u30f3\u30b0\u4e2d\u306b21 CFR Part 11\uff08\u7c73\u56fd\u9023\u90a6\u898f\u524721\u6761\u7b2c11\u7ae0\uff09\u3084PDMA\u306e\u8981\u4ef6\u306b\u5bfe\u3059\u308b\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u3092\u9075\u5b88\u3057\u306a\u304c\u3089\u533b\u85ac\u54c1\u306e\u30b5\u30f3\u30d7\u30ea\u30f3\u30b0\u30d7\u30ed\u30bb\u30b9\u3092\u5b9f\u65bd\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3059\u3002(\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001Veeva\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059\u3002\u539f\u6587\u306f\u3053\u3061\u3089<\/a><\/strong>\u304b\u3089\u304a\u8aad\u307f\u3044\u305f\u3060\u3051\u307e\u3059\u3002)<\/p>\n

 <\/p>\n

Veeva CRM<\/a><\/strong>\u62c5\u5f53\u30bc\u30cd\u30e9\u30eb\u30de\u30cd\u30fc\u30b8\u30e3\u30fc\u3067\u3042\u308bArno Sosna\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300cVeeva CRM Engage Meeting\u306f\u65b0\u305f\u306a\u30ea\u30e2\u30fc\u30c8\u696d\u52d9\u306e\u539f\u52d5\u529b\u3068\u3057\u3066\u3001\u533b\u5e2b\u304c\u7d99\u7d9a\u3057\u3066\u60a3\u8005\u30b1\u30a2\u3092\u7dad\u6301\u3057\u3066\u3044\u304f\u3053\u3068\u3092\u73fe\u5834\u62c5\u5f53\u8005\u304c\u652f\u63f4\u3067\u304d\u308b\u3088\u3046\u306b\u3057\u307e\u3059\u3002\u5f53\u793e\u306f\u88fd\u54c1\u306e\u5353\u8d8a\u6027\u3068\u6025\u901f\u306a\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u306b\u6ce8\u529b\u3059\u308b\u3053\u3068\u3067\u3001\u304a\u5ba2\u69d8\u304c\u65b0\u3057\u3044\u30c7\u30b8\u30bf\u30eb\u6a5f\u80fd\u3084\u30c1\u30e3\u30cd\u30eb\u3092\u8fc5\u901f\u306b\u5c55\u958b\u3067\u304d\u308b\u3088\u3046\u306b\u3057\u307e\u3059\u3002\u300d\"\"<\/p>\n

Veeva CRM Engage Meeting\u306f\u3001\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u3092\u9075\u5b88\u3057\u306a\u304c\u3089\u533b\u7642\u5f93\u4e8b\u8005\u3068\u306e\u30ea\u30e2\u30fc\u30c8\u30df\u30fc\u30c6\u30a3\u30f3\u30b0\u3092\u5bb9\u6613\u306b\u5b9f\u65bd\u3067\u304d\u308b\u3088\u3046\u306b\u3057\u307e\u3059\u3002\u4eca\u56de\u3001\u30ea\u30e2\u30fc\u30c8\u30b5\u30f3\u30d7\u30ea\u30f3\u30b0\u6a5f\u80fd\u304c\u65b0\u305f\u306b\u8ffd\u52a0\u3055\u308c\u305f\u3053\u3068\u306b\u3088\u308a\u3001\u8a2a\u554f\u3057\u3066\u306e\u9762\u8ac7\u306e\u5fc5\u8981\u306a\u304f\u533b\u85ac\u54c1\u30b5\u30f3\u30d7\u30eb\u3092\u63d0\u4f9b\u3067\u304d\u308b\u306b\u306a\u308a\u307e\u3059\u3002\u62c5\u5f53\u8005\u306f\u3001\u8a2a\u554f\u3059\u308b\u5834\u5408\u3068\u540c\u3058\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u30d7\u30ed\u30bb\u30b9\u306b\u5f93\u3063\u3066\u3001\u514d\u8a31\uff0f\u4f4f\u6240\u60c5\u5831\u3084\u30b5\u30f3\u30d7\u30eb\u306e\u8a73\u7d30\u3092\u78ba\u8a8d\u3057\u3001\u533b\u7642\u5f93\u4e8b\u8005\u306e\u7f72\u540d\u3092\u901a\u8a71\u8a18\u9332\u306e\u4e00\u90e8\u3068\u3057\u3066\u4fdd\u5b58\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002\u533b\u7642\u5f93\u4e8b\u8005\u306e\u7f72\u540d\u306e\u30ad\u30e3\u30d7\u30c1\u30e3\u30fc\u306f\u3001\u30e2\u30d0\u30a4\u30eb\u30c7\u30d0\u30a4\u30b9\u307e\u305f\u306f\u30d6\u30e9\u30a6\u30b6\u3092\u4f7f\u7528\u3057\u3066\u30aa\u30f3\u30e9\u30a4\u30f3\u3067\u884c\u3048\u307e\u3059\u3002<\/p>\n

\u307e\u305f\u3001Veeva CRM Engage Meeting\u306b\u306f\u3001\u30ea\u30e2\u30fc\u30c8\u306b\u304a\u3051\u308b\u533b\u5e2b\u554f\u3044\u5408\u308f\u305b\u7ba1\u7406\u6a5f\u80fd\u3068\u540c\u610f\u53d6\u5f97\u7ba1\u7406\u6a5f\u80fd\u304c\u8ffd\u52a0\u3055\u308c\u308b\u4e88\u5b9a\u3067\u3059\u3002\u3053\u308c\u3089\u306e\u65b0\u6a5f\u80fd\u306b\u3088\u308a\u3001\u73fe\u5834\u62c5\u5f53\u8005\u306fVeeva Engage Meeting\u3092\u4f7f\u7528\u3057\u3066\u3001\u533b\u7642\u5f93\u4e8b\u8005\u304b\u3089\u306e\u554f\u3044\u5408\u308f\u305b\u5185\u5bb9\u306e\u78ba\u8a8d\u3068\u7f72\u540d\u53d6\u5f97\u3001\u3055\u3089\u306b\u533b\u7642\u5f93\u4e8b\u8005\u304c\u5e0c\u671b\u3059\u308b\u60c5\u5831\u63d0\u4f9b\u30c1\u30e3\u30cd\u30eb\u306e\u627f\u8afe\u3092\u3001\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u3092\u9075\u5b88\u3057\u306a\u304c\u3089\u30ea\u30e2\u30fc\u30c8\u3067\u5bfe\u5fdc\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3059\u3002<\/p>\n

\u3053\u308c\u3089\u306e\u6700\u65b0\u306e\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u306f\u3001\u696d\u754c\u306e\u6025\u901f\u306a\u30c7\u30b8\u30bf\u30eb\u30b7\u30d5\u30c8\u3092\u7d99\u7d9a\u3057\u3066\u652f\u3048\u307e\u3059\u30022020\u5e743\u6708\u4ee5\u6765\u3001Veeva\u306f\u533b\u7642\u5f93\u4e8b\u8005\u3068\u306e\u3064\u306a\u304c\u308a\u3092\u7dad\u6301\u3067\u304d\u308b\u3088\u3046\u306b\u3001\u65b0\u898f\u306e\u304a\u5ba2\u69d8\u306bVeeva CRM Engage Meeting\u3092\u7121\u6599\u3067\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u304c\u3053\u306e3\u6708\u306b\u30aa\u30f3\u30e9\u30a4\u30f3\u3067\u3084\u308a\u53d6\u308a\u3057\u305f\u533b\u7642\u5f93\u4e8b\u8005\u306e\u6570\u306f10\u4e07\u4eba\u4ee5\u4e0a\u306b\u4e0a\u308a[1]<\/sup><\/a>\u30011\u6708\u3068\u6bd4\u8f03\u3057\u30662,347%\u5897\u52a0\u3057\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u3001\u3053\u3046\u3057\u305f\u30ea\u30e2\u30fc\u30c8\u30df\u30fc\u30c6\u30a3\u30f3\u30b0\u306f\u901a\u5e38\u306e\u8a2a\u554f\u9762\u8ac7[2]<\/sup><\/a>\u3068\u6bd4\u3079\u3066\u3088\u308a\u8a73\u7d30\u306a\u5185\u5bb9\u306b\u306a\u308b\u305f\u3081\u3001\u5e73\u5747\u306713\u5206\u9577\u3044[3]<\/sup><\/a>\u3053\u3068\u304c\u308f\u304b\u3063\u3066\u3044\u307e\u3059\u3002<\/p>\n

\u30ea\u30e2\u30fc\u30c8\u30b5\u30f3\u30d7\u30ea\u30f3\u30b0\u6a5f\u80fd\u306f\u3001\u3059\u3067\u306bVeeva CRM Engage Meeting\u3067\u3054\u5229\u7528\u3044\u305f\u3060\u3051\u307e\u3059\u3002\u30ea\u30e2\u30fc\u30c8\u554f\u3044\u5408\u308f\u305b\u7ba1\u7406\u6a5f\u80fd\u304a\u3088\u3073\u30ea\u30e2\u30fc\u30c8\u540c\u610f\u7ba1\u7406\u6a5f\u80fd\u306f\u3001\u4eca\u5f8c\u6570\u30ab\u6708\u4ee5\u5185\u306b\u5229\u7528\u53ef\u80fd\u306b\u306a\u308b\u4e88\u5b9a\u3067\u3059\u3002Veeva CRM Engage Meeting\u306e\u8a73\u7d30\u306fveeva.com\/jp\/EngageMeeting<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n

[1] Veeva HCP Pulse\u304b\u3089\u306e\u5185\u90e8\u30c7\u30fc\u30bf\u306b\u57fa\u3065\u304d\u307e\u3059<\/span>
\n[2] Pharma Sales Reps are Struggling \u2013 Here\u2019s Why. BlueNovius. May 2018<\/a>.<\/span>
\n[3] Veeva HCP Pulse\u304b\u3089\u306e\u5185\u90e8\u30c7\u30fc\u30bf\u306b\u57fa\u3065\u304d\u307e\u3059<\/span><\/p>\n

 <\/p>\n

\u3010<\/strong>Veeva Systems<\/strong>\u793e\u306b\u3064\u3044\u3066\u3011<\/strong>
\nVeeva Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u5411\u3051\u306b\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067\u3001850\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u306b\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u306b\u30b3\u30df\u30c3\u30c8\u3059\u308b\u69d8\u3005\u306a\u30b5\u30fc\u30d3\u30b9\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002Veeva\u306f\u3001\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u306e\u30d9\u30a4\u30a8\u30ea\u30a2\u306b\u672c\u793e\u3092\u7f6e\u304d\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u306b\u62e0\u70b9\u3092\u5c55\u958b\u3057\u3066\u3044\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001https:\/\/veeva.com\/jp\/<\/a>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n

\u3010Forward-looking Statements\u3011
\nThis release contains forward-looking statements, including the market demand for and acceptance of Veeva\u2019s products and services, the results from use of Veeva\u2019s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on F Form 10-K for the period ended January\u00a031, 2020. This is available on the company\u2019s website at www.veeva.com<\/a> under the Investors section and on the SEC\u2019s website at www.sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.<\/p>\n","protected":false},"excerpt":{"rendered":"

\u65b0\u6a5f\u80fd\u3067\u533b\u5e2b\u304c\u7d99\u7d9a\u3057\u3066\u60a3\u8005\u30b1\u30a2\u3092\u7dad\u6301\u3057\u3066\u3044\u304f\u305f\u3081\u306b\u73fe\u5834\u62c5\u5f53\u8005\u3092\u652f\u63f4<\/p>\n","protected":false},"author":131,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322,341],"tags":[],"class_list":["post-43535","post","type-post","status-publish","format-standard","hentry","category-press-release","category-case-study"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/43535"}],"collection":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=43535"}],"version-history":[{"count":10,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/43535\/revisions"}],"predecessor-version":[{"id":43547,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/43535\/revisions\/43547"}],"wp:attachment":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=43535"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=43535"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=43535"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}